Oxford Industries (OXM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 24, 2025, to be held virtually at 2:00 P.M. Eastern time.
Shareholders can access proxy materials and vote online or request paper copies.
Board recommends voting FOR all director nominees and FOR Proposals 2 and 3.
Voting matters and shareholder proposals
Election of three Class III directors for a three-year term expiring in 2028: Helen Ballard, Virginia A. Hepner, and Milford W. McGuirt.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal 2025.
Advisory, non-binding vote to approve compensation of named executive officers.
Proxies may vote on other matters as recommended by the Board.
Board of directors and corporate governance
Board recommends all director nominees for election.
Director terms set for three years, expiring in 2028 for Class III nominees.
Latest events from Oxford Industries
- Q1 sales and earnings fell, but FY24 growth and investment are expected despite headwinds.OXM
Q1 20253 Feb 2026 - Earnings and margins fell on flat sales as guidance was cut and capex increased for growth.OXM
Q2 202520 Jan 2026 - Cost controls, sourcing shifts, and brand focus aim to drive a 2026 recovery after a tough 2025.OXM
28th Annual ICR Conference 202612 Jan 2026 - Q3 sales and earnings declined, with 2024 guidance lowered amid ongoing macro headwinds.OXM
Q3 202511 Jan 2026 - Strong brands, resilient margins, and strategic investments set the stage for 2025 growth.OXM
27th Annual ICR Conference 202510 Jan 2026 - 2024 sales and earnings fell; 2025 outlook flat with ongoing headwinds and strong capital returns.OXM
Q4 202526 Dec 2025 - $63.7M Q3 loss on flat sales, hit by $61M impairments and tariff-driven margin pressure.OXM
Q3 202612 Dec 2025 - Shareholders will vote on directors, auditor ratification, and executive pay, with a focus on governance.OXM
Proxy Filing1 Dec 2025 - Q1 2025 met guidance, but outlook cut as tariffs and costs pressured margins and earnings.OXM
Q1 202614 Nov 2025